---
title: "ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE"
ocid: "ocds-h6vhtk-029301"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029301"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-029301.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-029301.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "BUSINESS ENERGY AND INDUSTRIAL STRATEGY"
published: "2021-02-12"
---

# ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE

Buyer: BUSINESS ENERGY AND INDUSTRIAL STRATEGY  
Current stage: Award  
OCID: ocds-h6vhtk-029301

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029301)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-029301.json)

## Summary

The public procurement process involves an advance purchase agreement for the SARS-CoV-2/COVID-19 vaccine, primarily managed by the Business Energy and Industrial Strategy, located at 1 Victoria Street, London, UK. This procurement falls under the goods category, specifically dealing with vaccines, and was initiated under extreme urgency without prior publication as per the Public Contracts Regulations 2015. The contract was signed on 15 January 2021, and the award has been made to Janssen Pharmaceutica NV, with the procurement conducted using a limited method due to the urgent requirement arising from the pandemic.

This tender represents a significant opportunity for businesses involved in pharmaceutical manufacturing, particularly those developing vaccine candidates. Companies offering related healthcare products or services may also find viable opportunities to engage in supply chains or related contracts. With the heightened demand for vaccines during the ongoing pandemic, this procurement opens doors for manufacturers and suppliers capable of delivering critical products quickly, offering them a chance to expand their market reach and contribute to public health efforts.

## Notice

Procurement of Janssen's vaccine candidate Ad26.COV2-S.

### Lot Information

Lot 1

This contract has been procured using the negotiated procedure without prior publication under regulation 32 of the Public Contracts Regulations 2015 on the basis that the award of the contract to Janssen is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to secure priority access to a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)). Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors.

### Procurement Information

The award of the contract to Janssen is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid 19 pandemic (Regulation 32(2)(c)).

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/002970-2021 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 12 Feb 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 15 Jan 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | BUSINESS ENERGY AND INDUSTRIAL STRATEGY |
| Locality | LONDON |
| Post town | South West London |
| Postcode | SW1H 0ET |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI35 Westminster and City of London |
| Local authority | Westminster |
| Electoral ward | St James's |
| Westminster constituency | Cities of London and Westminster |
| Delivery location | TLE Yorkshire and The Humber |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | JANSSEN PHARMACEUTICA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651600 - Vaccines

## Release History

- 12 Feb 2021 at 17:45 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/002970-2021

## Notice URLs

- https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029301. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-029301.json.